---
schema_version: "secwatch.filing_event.v1"
accession: "0001709164-24-000022"
form_type: "8-K"
ticker: "HBB"
cik: "0001709164"
company_name: "Hamilton Beach Brands Holding Co"
filed_at: "2024-05-07T23:59:59+00:00"
generated_at: "2026-06-02T19:09:19.518126+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Hamilton Beach Q1 operating loss narrows to $0.9M; gross margin up 710 bps

## Summary
- Revenue flat at $128.3M; gross profit margin improved to 23.4% from 16.3%.
- Operating loss of $0.9M vs. $5.1M a year ago; net loss $1.2M ($0.08/share) vs. $4.8M ($0.34/share).
- Completed acquisition of HealthBeacon PLC on Feb 2, 2024; added $1.1M operating loss and $1.0M transaction costs.
- Net debt reduced to $23.7M from $77.1M a year ago; paid $1.5M in dividends.
- Affirmed FY 2024 outlook: modest revenue growth, moderate operating profit increase, upside if consumer spending holds.

## SEC filing metadata
- accession: 0001709164-24-000022
- form_type: 8-K
- ticker: HBB
- cik: 0001709164
- company_name: Hamilton Beach Brands Holding Co
- filed_at: 2024-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1709164/000170916424000022/0001709164-24-000022-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1709164/000170916424000022/hbb-20240507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001709164-24-000022
- JSON: https://secwatch.observer/filing/0001709164-24-000022.json
- Plain text: https://secwatch.observer/filing/0001709164-24-000022.txt

## Key facts
- Earnings Releases
  Hamilton Beach Brands Holding Co reported first quarter ended March 31, 2024 results: revenue $128.3 million, net income Net loss was $1.2 million, or $0.08 per diluted share, EPS $0.08 per diluted share. Guidance reaffirmed.
  - Period: first quarter ended March 31, 2024
  - Revenue: $128.3 million
  - Net income: Net loss was $1.2 million, or $0.08 per diluted share
  - EPS: $0.08 per diluted share
  - Guidance: reaffirmed
  - Result: reported results
  source text: 23.4 % 16.3 % Operating profit (loss) $ (0.9) $ (5.1) Cash flow from operating activities $ 19.7 $ 34.9 Total debt $ 50.0 $ 79.3 Net debt $ 23.7 $ 77.1 • Total revenue of $128.3 million was flat to a year ago • Gross profit margin improved 710 basis points to 23.4% compared to 16.3% • Operating loss was $0.9 million versus a loss of $5.1 million a year ago •
  evidence_url: https://www.sec.gov/Archives/edgar/data/1709164/000170916424000022/0001709164-24-000022-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
